L-PPDS

· Mati Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for L-PPDS, covering 2013-09-19 to 2014-01-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAG [Phase 2]